GlassScriptPhysician profile
Jay R Trabin
NPI 1508978032
$2,082.31
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $370 · 2020: $27.98 · 2021: $1,672 · 2022: $13.01.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scynexis, INC. | $1,557.50 | 2021 | |
| Abbvie INC. | $175.00 | 2019-2021 | |
| Allergan, INC. | $49.49 | 2019 | |
| Amag Pharmaceuticals, INC. | $46.77 | 2019 | |
| Lupin INC. | $43.62 | 2019-2021 | |
| Astellas Pharma US INC | $42.32 | 2019 | |
| Therapeuticsmd, INC. | $39.15 | 2019-2020 | |
| Pfizer INC. | $24.09 | 2019-2022 | |
| Radius Health, INC. | $21.92 | 2019 | |
| Merz North America, INC. | $19.31 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.83 | 2019 | |
| Myovant Sciences INC. | $16.21 | 2021 | |
| Exeltis, USA INC. | $15.03 | 2019 | |
| Tactile Systems Technology INC | $14.07 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Trabin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.